疱疹+湿疣; about Panavir [复制链接]

由于贪花好色,本人于2006年6,7月份首发湿疣,后又有疱疹,开始疱疹不怎么严重,湿疣才是心头大患
一开始治疗也不得当,很后悔做了什么激光,弄得终身留疤,无比后悔,其实用用疣迪搽剂和咪喹莫特最实用了

就这么一年多来在于湿疣的对抗中我最终好像占据了上风--可疱疹兴风作浪了:

记得今年7月份一次湿疣/疱疹大爆发到最近又发作了,湿疣就那么一小处可疱疹厉害了--(先开始痒痛,10月5日左右)右侧阴囊无比痛楚,泡大且密集,龟头不痛可有小泡,都一个礼拜了(服用阿昔),虽有好转可下一次呢......心情失落沮丧到极点

我相信疣是可以战胜的,临床治愈不复发的大有人在,可疱疹呢....(我曾经还心想宁可患疱疹也不要湿疣,现在恰恰相反)
到国外的论坛看看:
http://www.herpes-coldsores.com/messageforum/
http://www.racoon.com/cgi-bin/dcforum/dcboard.cgi
10年20年的大有人在,心一下子凉了....

看到Panavir的网站,有种想去俄罗斯的冲动:
The experience of Panavir application in treatment of patients with herpes

Moscow 2002            


As one of alternative means we had used Panavir for intravenous introduction in treatment of genital herpes.          
The main active substance of the medication Panavir is a polysaccharide extracted out from the plant (potato sprouts).              
We applied Panavir to
100 patients with genital herpes. Among them 42 were men and 58 – women, from 18 to 57 years of age. Duration of disease varied from 1 year to 15 years, length of relapse varied from 4 to 8 days; by frequency of relapses the patients were arranged thus: 15 patients had
marked relapses 2-3 times per month; 41 patients - 1 time per month;  44 patients had a relapse 5-6 times per year.
For treatment all the patients had taken earlier other antiviral drugs
intravenously, per os and externally, but unfortunately, relapses had
remained. As an injection solution,
Panavir was administered to be given as the outbreak appeared
intravenously two times at the interval of 24 hours. Simultaneously 35 patients were prescribed
to apply
the gel Panavir
topically onto
lesions 3-4 times per day. The control inspection was due
to be passed on the 7th
day from the beginning of the treatment.                  
Reduction of relapse duration up to 2-4 days was observed in 86 patients,  relapse duration of 14 patients had shortened
insignificantly, up
to 5-7 days. All the patients had noticed
rapid
disappearance of subjective sensations such as itching and  burning senses, acceleration of
scabs forming processes and epithelization. The patients applied
the gel noticed
marked antiphlogistic, anesthetizing and healing extra effects.    
While overseeing the patients within 6 months, 64 of them had been watched a remission; interrecurrent period of 28 patients had been enlarged twice; the amount of relapses of 8 patients had remained former.    



The drug
Panavir was applied to 205 patients with recurrent herpes appeared on labiums.            

At the applying to the doctor 112 patients were observed vesiculous rashes on a red line of labiums, hydrops, itching and burning senses. The recurrence rate averaged one time per two months having enlarged
up to two times per month in autumn-winter period. The patients were
administered intravenous introduction of Panavir twice
at
the interval of 24-48 hours and application of
protective gel Panavir
topically on the
lesions 4-6 times a day within 7 days. At the second injection
all the patients marked stoppage of itching, burning and pricking senses. In 1-2 days from the beginning of the treatment, in 103 patients vesicles dissipated; on their place scabs had been forming, which had fallen off in 2-3 days. In 9 patients the development of relapse had occurred without changes and had completed
on  the 7-8th
day. 97 patients had not had recurrences
within 6 months of observation. Recurrence rate of 15 patients had decreased by 2-3 times.


93 patients applied to the doctor at the appearing of initial subjective malaises such as prickings, burning, itching in the places of usual herpes exhibitings on labiums. The drug was administered intravenously one time.

While applying the medication, 69 patients had not had a relapse; 13 had been watched an abortive form with
tumescence and hyperemia, which had kept
for 3-4 days; complaints for itching and burning sense were marked.
11 patients, who had been watched
development of a relapse, were administered
the medication Panavir twice
intravenously and the gel Panavir
topically 4 times a day within 7 days. The duration of relapse was reduced
by 3 days.        

4 patients with the diagnosis of surrounding herpes from 45 to 67 years of age applied to the clinic. All the patients, who
were of corpulent type, complained for numerous dermal lesions and expressed pain syndrome. All of them were administered
Panavir
under the scheme: intravenously,
on the 1st  and the 2nd day - in a dose of 10,0 mls; the 3rd , the 4th day - in a dose of 5,0 mls. All the patients had noted
marked decrease of inflammatory processes and the reduction of pain syndrome duration. On the 3d –4th
day scabs had been forming on the place of vesicles with the following
epithelization of affected surfaces. The duration of relapse was reduced
to 7-8 days. The recurrences
had not been reoccurred within the period of observation (no less than 1 year).  




Thus, it is possible to conclude that:
· The medication
Panavir is a high effective antiviral drug
showing expressed influence on recurrence course of genital herpes.
· The use of Panavir had
found
an effective as the first symptoms of disease are appeared.

· It is shown a high effectiveness of Panavir
in treatment of recurrent genital herpes (RGH), herpes - labialis
and surrounding herpes.
· Protective
gel Panavir appeared to be effective for relieving inflammatory processes
and as a wound healing remedy.
· Good tolerance to the drug was marked by the patients.




Chief of  the Department of Dermal and Venereal Illnesses of the Russian State Medical University ,
Member of the Russian Academy
of Medical
Sciences,
Doctor of Medicine Sciences
                                                 Scripkin Y.К.

从文章看效果很好,可2002年的东东如果效果那么好怎么在国外论坛上看都看不到,无非是Valtrex(Valaciclovir Hydrochloride)之类
hi!就算去俄罗斯那边医院里不见得就有

接下去该怎么办呢?.................
而且这时碰上自己喜欢的女孩,人世间的痛苦莫过于此,虽然我们比HIV,恶性癌症,缺胳膊少腿看不见的人等要幸运点,可也好不到哪儿去
郁闷哪郁闷,幸福在哪里.......